睡眠辅助产品市场规模、份额及成长分析(依产品类型、剂型、通路、最终用户及地区划分)-2026-2033年产业预测
市场调查报告书
商品编码
1919961

睡眠辅助产品市场规模、份额及成长分析(依产品类型、剂型、通路、最终用户及地区划分)-2026-2033年产业预测

Sleeping Aids Market Size, Share, and Growth Analysis, By Product Type (Prescription Sleeping Aids, Over-the-Counter (OTC) Sleeping Aids), By Form, By Distribution Channel, By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 197 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球助眠产品市场规模预计在 2024 年达到 129 亿美元,从 2025 年的 137.1 亿美元成长到 2033 年的 223.6 亿美元,在预测期(2026-2033 年)内复合年增长率为 6.3%。

全球助眠产品市场正经历强劲成长,这主要得益于睡眠障碍盛行率的上升以及人们对优质睡眠重要性认识的不断提高。消费者越来越倾向于寻求针对自身特定需求的个人治疗方法,从而推动了市场向注重整体健康的天然、个人化解决方案的转变。科技进步进一步促进了这一转变,催生出更多创新产品和智慧治疗方法,显着提升了疗效和使用者舒适度。然而,市场也面临日益严格的监管审查,为企业带来了许多挑战,例如漫长的核准流程和对新产品推出的犹豫。如何在不断发展的助眠产品产业中平衡监管合规性、确保安全性和满足市场对创新产品的需求,是一项复杂的挑战。

全球助眠产品市场驱动因素

全球助眠产品市场正经历显着成长,这主要得益于人们对优质睡眠重要性的日益重视。随着越来越多的人寻求专业协助来解决入睡和保持睡眠方面的问题,消费者的行为发生了显着变化,从而推动了对各种睡眠解决方案的需求。这种日益增长的意识不仅推动了市场的发展,也促进了药品和非药品产品的创新和普及。因此,为了满足希望改善整体睡眠品质的消费者多样化的需求,业界涌现出更多种类的助眠产品。

全球助眠产品市场限制因素

全球助眠产品市场面临严格监管的巨大挑战。产品测试和新治疗方法核准流程漫长,严重阻碍了创新解决方案的及时上市。这种漫长的安全性和有效性验证要求,不仅限制了新产品的快速推广,还可能对製造商的创新能力和应对力消费者需求的能力产生不利影响。因此,合规问题造成的延误会抑制市场成长,限制消费者获得有效助眠产品的机会,最终对整个产业的发展和扩张构成挑战。

全球助眠产品市场趋势

全球睡眠辅助产品市场正经历显着的变革,这主要得益于不断涌现的、旨在提升睡眠体验的技术创新。各公司纷纷推出种类繁多的智慧产品和解决方案,包括智慧床垫、睡眠追踪设备和行动应用程序,为消费者提供个人化的睡眠模式分析。这一趋势赋予消费者更大的参与度和对睡眠品质的掌控权,从而推动了智慧科技辅助产品的广泛应用。随着消费者寻求更有效、更具互动性的睡眠改善方式,市场持续扩张,提供更多满足个人需求的客製化选择,并协助提升整体健康水准。

目录

介绍

  • 调查目标
  • 市场定义和范围

调查方法

  • 调查过程
  • 二手资料和一手资料方法
  • 市场规模估算方法

执行摘要

  • 全球市场展望
  • 市场主要亮点
  • 细分市场概览
  • 竞争格局概述

市场动态与展望

  • 总体经济指标
  • 驱动因素和机会
  • 限制与挑战
  • 供给面趋势
  • 需求面趋势
  • 波特的分析和影响

关键市场考察

  • 关键成功因素
  • 影响市场的因素
  • 关键投资机会
  • 生态系测绘
  • 市场吸引力指数(2025)
  • PESTEL 分析
  • 价值链分析
  • 定价分析
  • 案例研究
  • 监管环境
  • 技术评估
  • 技术评估
  • 监管环境

全球助眠产品市场规模(依产品类型及复合年增长率划分)(2026-2033 年)

  • 处方助眠药
  • 非处方(OTC)助眠药
  • 天然草本助眠补充剂

全球助眠产品市场规模(依剂型及复合年增长率划分)(2026-2033 年)

  • 片剂和胶囊
  • 液体
  • 粉末
  • 其他的

全球助眠产品市场规模(依通路划分)及复合年增长率(2026-2033 年)

  • 医院药房
  • 零售药房
  • 网路药房
  • 专卖店

全球助眠产品市场规模(依最终用户划分)及复合年增长率(2026-2033 年)

  • 成人
  • 老年人
  • 其他的

全球助眠产品市场规模及复合年增长率(2026-2033)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2025 年)
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Pfizer
  • Sanofi
  • Novartis
  • Johnson & Johnson
  • GlaxoSmithKline
  • Takeda Pharmaceutical Company
  • Teva Pharmaceutical Industries
  • Bayer AG
  • Eisai Co., Ltd.
  • Merck & Co.
  • Boehringer Ingelheim
  • Mylan
  • Sun Pharmaceutical
  • Dr. Reddy's Laboratories
  • Lupin Limited
  • Natura Health Products
  • Herbaland Naturals
  • Nature's Bounty
  • NOW Foods
  • Vitabiotics

结论与建议

简介目录
Product Code: SQMIG35A3177

Global Sleeping Aids Market size was valued at USD 12.9 billion in 2024 and is poised to grow from USD 13.71 billion in 2025 to USD 22.36 billion by 2033, growing at a CAGR of 6.3% during the forecast period (2026-2033).

The global sleeping aids market is witnessing robust growth fueled by the rising prevalence of sleep disorders and a growing awareness of the importance of quality sleep. Consumers are increasingly seeking remedies tailored to their specific needs, prompting a shift toward natural and personalized solutions that emphasize holistic wellness. This transformation is further supported by technological advancements, resulting in innovative products and smarter therapies that enhance efficacy and user comfort. However, the landscape is also characterized by increased regulatory scrutiny, which poses challenges for businesses, leading to longer approval processes and hesitation in adopting new solutions. Balancing regulatory compliance and safety concerns with the demand for groundbreaking products presents a complex dynamic in the evolving sleeping aids industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sleeping Aids market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sleeping Aids Market Segments Analysis

Global Sleeping Aids Market is segmented by Product Type, Form, Distribution Channel, End User and region. Based on Product Type, the market is segmented into Prescription Sleeping Aids, Over-the-Counter (OTC) Sleeping Aids and Natural & Herbal Sleep Supplements. Based on Form, the market is segmented into Tablets & Capsules, Liquids, Powders and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Specialty Stores. Based on End User, the market is segmented into Adults, Geriatric Population and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Sleeping Aids Market

The global market for sleeping aids is experiencing significant growth, driven by an increasing awareness of the importance of quality sleep. As individuals seek professional help to address issues related to falling asleep or maintaining slumber, there is a noticeable shift in consumer behavior that fuels the demand for various sleep solutions. This rising awareness not only propels the market forward but also fosters innovation and greater accessibility in both pharmaceutical and non-pharmaceutical products. Consequently, the industry is witnessing a broader range of sleep aid options, meeting the diverse needs of consumers looking to enhance their overall sleep quality.

Restraints in the Global Sleeping Aids Market

The Global Sleeping Aids market faces notable challenges due to stringent oversight by regulatory authorities. The lengthy processes associated with product inspections and approvals for new treatments significantly hinder the timely introduction of innovative solutions. This prolonged requirement for demonstrating safety and efficacy can obstruct the rapid rollout of new offerings, negatively impacting the ability of manufacturers to innovate and respond to consumer needs. Consequently, delays resulting from compliance issues can stifle market growth and limit access for consumers seeking effective sleep aid solutions, ultimately challenging the development and expansion of the industry as a whole.

Market Trends of the Global Sleeping Aids Market

The Global Sleeping Aids market is experiencing a notable shift driven by continuous technological innovations that enhance the sleep experience. Companies are introducing a range of smart products and solutions, such as connected mattresses, sleep tracking devices, and mobile applications, which provide consumers with personalized insights into their sleep patterns. This trend allows for increased consumer engagement and control over sleep quality, leading to a broader acceptance of smart, tech-oriented aids. As consumers seek more effective and interactive methods for improving sleep, the market is expanding, offering diverse options tailored to individual needs and elevating overall well-being.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Technology Assessment
  • Technology Assessment
  • Regulatory Landscape

Global Sleeping Aids Market Size by Product Type & CAGR (2026-2033)

  • Market Overview
  • Prescription Sleeping Aids
  • Over-the-Counter (OTC) Sleeping Aids
  • Natural & Herbal Sleep Supplements

Global Sleeping Aids Market Size by Form & CAGR (2026-2033)

  • Market Overview
  • Tablets & Capsules
  • Liquids
  • Powders
  • Others

Global Sleeping Aids Market Size by Distribution Channel & CAGR (2026-2033)

  • Market Overview
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Stores

Global Sleeping Aids Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Adults
  • Geriatric Population
  • Others

Global Sleeping Aids Market Size & CAGR (2026-2033)

  • North America (Product Type, Form, Distribution Channel, End User)
    • US
    • Canada
  • Europe (Product Type, Form, Distribution Channel, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Form, Distribution Channel, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Form, Distribution Channel, End User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Form, Distribution Channel, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Pfizer
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takeda Pharmaceutical Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eisai Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mylan
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sun Pharmaceutical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dr. Reddy's Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lupin Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Natura Health Products
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Herbaland Naturals
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nature's Bounty
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NOW Foods
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitabiotics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations